Cecília Rajda: Influence Statistics

Cecília Rajda

Cecília Rajda

Department of Neurology, Faculty of Medicine, University of Szeged, Szeged, Hungary | Department of Neurology, Interdisciplinary Centre of Excellence, Faculty of Medicine, ...

Cecília Rajda: Expert Impact

Concepts for which Cecília Rajda has direct influence: Multiple sclerosis , Csongrád county , Redox disturbances , Clinical forms , Central nervous , Sclerosis patients , Cerebrospinal fluid .

Cecília Rajda: KOL impact

Concepts related to the work of other authors for which for which Cecília Rajda has influence: Multiple sclerosis , Cerebrospinal fluid , Kynurenine pathway , Clinically isolated syndrome , Human herpesvirus , Central nervous , Oligoclonal bands .

KOL Resume for Cecília Rajda

Year
2021

Department of Neurology, Faculty of Medicine, University of Szeged, Szeged, Hungary

2020

Department of Neurology, Faculty of Medicine, University of Szeged, Semmelweis u. 6., H-6725 Szeged, Hungary;, (H.P.);, (K.B.);, (L.V.)

2018

Szegedi Tudományegyetem, Neurológiai Klinika, Szeged.

2017

Department of Neurology, University of Szeged, 6725 Szeged, Hungary;, (C.R.);, (D.P.);, (Z.B.);, (Z.M.)

2016

University of Szeged, Department of Neurology, Szeged, Hungary.

2015

Department of Neurology, University of Szeged, Szeged H-6725, Hungary; E-Mails:, (C.R.);, (Z.M.);, (D.P.)

2014

Neurology Department, Faculty of Medicine, University of Szeged, Szeged, Hungary.

2012

Department of Neurology, Faculty of Medicine, Albert Szent-Györgyi Clinical Centre, University of Szeged, Semmelweis u. 6, 6725, Szeged, Hungary

2010

Department of Neurology, Albert Szent-Györgyi Clinical Centre, University of Szeged, Szeged, Hungary

2009

Department of Neurology, Albert Szent-Györgyi Clinical Centre, University of Szeged, 6 Semmelweis u., H-6725, Szeged, Hungary

2008

Department of Neurology, Albert Szent-Györgyi Medical and Pharmaceutical Center, University of Szeged, Szeged

2007

University of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary

2006

Department of Neurology, Albert Szent-Györgyi Medical and Pharmaceutical Center, University of Szeged, Semmelweis u. 6., H-6725 Szeged, Hungary, Department of Psychiatry and Neurochemistry, Institute of Clinical Neuroscience, Göteborg University, Sahlgrenska University Hospital Mölndal, SE-431 80 Mölndal, Sweden

2005

Department of Neurology, Albert Szent‐Györgyi Medical and Pharmaceutical Center, University of Szeged, Szeged, Hungary

2003

Department of Neurology, University of Szeged, Semmelweis u. 6, H-6725 Szeged, Hungary

2002

Department of Psychiatry and Neurochemistry, Institute of Clinical Neuroscience, Göteborg University, Sahlgrenska University Hospital Mölndal, SE-431 80 Mölndal, Sweden

2001

Department of Neurology, Faculty of General Medicine, Albert Szent-Györgyi Medical and Pharmaceutical Center, University of Szeged, Hungary

1999

From the Department of Neurology, Albert Szent‐Györgyi Medical University, Szeged, Hungary (Rajda, Tajti, Seres, Klivényi, and Vécsei), and

1998

Department of Neurology, Albert Szent‐Gyorgyi Medical Uniersity, Szeged, Hungary

Prominent publications by Cecília Rajda

KOL-Index: 8100 . BACKGROUND AND OBJECTIVE: We explored which clinical and biochemical variables predict conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS) in a large international cohort. METHODS: Thirty-three centres provided serum samples from 1047 CIS cases with at least two years' follow-up. Age, sex, clinical presentation, T2-hyperintense lesions, ...
Known for Multiple Sclerosis | Clinically Isolated Syndrome | Conversion Cdms | Csf Igg
KOL-Index: 7208 . OBJECTIVE: To validate kappa free light chain (KFLC) and lambda free light chain (LFLC) indices as a diagnostic biomarker in multiple sclerosis (MS). METHODS: We performed a multicenter study including 745 patients from 18 centers (219 controls and 526 clinically isolated syndrome (CIS)/MS patients) with a known oligoclonal IgG band (OCB) status. KFLC and LFLC were measured in paired ...
Known for Ocb Kflc | Sensitivity Specificity | Light Chains | Kappa Free
KOL-Index: 6762 . OBJECTIVE: The aim of this study was to determine the prevalence of multiple sclerosis (MS) in the population of Csongrád County, Hungary (400,128 inhabitants) and to determine the functional status (based on the Expanded Disability Status Scale; EDSS) of the patients according to the clinical forms of the disease. METHODS: The diagnosis was established with the aid of the Poser diagnostic ...
Known for Csongrád County | Multiple Sclerosis | Clinical Forms | Relapsing Remitting
KOL-Index: 6523 . Tryptophan and its metabolites are of great interest in understanding the pathogenesis of multiple sclerosis (MS). The total levels of tryptophan and its metabolites, kynurenine and kynurenic acid were determined in plasma by capillary liquid chromatography electrospray ionisation tandem mass spectrometry. This is the first report of the plasma levels of these analytes in healthy controls ...
Known for Multiple Sclerosis | Metabolites Kynurenine | Kynurenic Acid | Tryptophan Metabolism
KOL-Index: 6180 . Health-related quality of life measurements are gaining more importance in the study and clinical practice of multiple sclerosis. The aim of our study was the adaptation of the Multiple Sclerosis Quality of Life Instrument (MSQOL-54) in Hungarian. The study was carried out at the Department of Neurology, University of Szeged and two other multiple sclerosis centers. The Hungarian ...
Known for Multiple Sclerosis | Quality Life | Msqol54 Instrument | Hungarian Version
KOL-Index: 5742 . Neurofilament light (NFL) has proved to be a good prognostic factor in multiple sclerosis (MS), as its level is proportionally elevated with extended neuraxonal damage. The involvement of the kynurenine pathway in neuroinflammation has been proved. The precursor of this pathway is the essential amino acid tryptophan, which is catabolized 95% towards kynurenine metabolites. Quinolinic acid ...
Known for Multiple Sclerosis | Neurofilament Light | Kynurenine Pathway | Cerebrospinal Fluid
KOL-Index: 5742 . There is a long history of research into body fluid biomarkers in neurodegenerative and neuroinflammatory diseases. However, only a few biomarkers in cerebrospinal fluid (CSF) are being used in clinical practice. Anti-aquaporin-4 antibodies in serum are currently useful for the diagnosis of neuromyelitis optica (NMO), but we could expect novel CSF biomarkers that help define prognosis and ...
Known for Biomarker Studies | Csf Samples | Preanalytical Factors | Neuromyelitis Optica
KOL-Index: 5638 . Tryptophan is one of the essential amino acids, 80% of which is catabolised in the extrahepatic tissues by indoleamine-2,3-dioxygenase (IDO), the rate-limiting enzyme of the kynurenine pathway. Metabolites along the kynurenine pathway have been implicated to play a role in the pathomechanism of neuroinflammatory and neurodegenerative disorders. Changes in the concentration levels of ...
Known for Multiple Sclerosis | Kynurenine Pathway | Amyotrophic Lateral | Neurodegenerative Diseases
KOL-Index: 5502 . The simultaneous quantitative estimation of tryptophan (TRP) and its metabolites represents a great challenge because of their diverse chemical properties, e.g., presence of acidic, basic, and nonpolar functional groups and their immensely different concentrations in biological matrices. A short ultra high-performance liquid chromatography (UHPLC)-tandem mass spectrometry (MS/MS) method ...
Known for Multiple Sclerosis | Tryptophan Metabolites | Kynurenic Acid | Kyn Kyna
KOL-Index: 5470 . Multiple sclerosis is an inflammatory disease of the central nervous system, in which axonal transection takes place in parallel with acute inflammation to various, individual extents. The importance of the kynurenine pathway in the physiological functions and pathological processes of the nervous system has been extensively investigated, but it has additionally been implicated as having a ...
Known for Multiple Sclerosis | Central Nervous | Kynurenine Pathway | Autoimmune Diseases
KOL-Index: 5446 . PurposeFatigue is one of the most frequent complaints of patients with multiple sclerosis (MS). The Fatigue Impact Scale (FIS), one of the 30 available fatigue questionnaires, is commonly applied because it evaluates multidimensional aspects of fatigue. The main purposes of this study were to test the validity, test–retest reliability, and internal consistency of the Hungarian version of ...
Known for Fatigue Impact Scale | Patients Multiple Sclerosis | Internal Consistency | Hungarian Version
KOL-Index: 5365 . Tumour necrosis factor alpha (TNF-alpha) is associated with clinical activity in relapsing-remitting multiple sclerosis (RRMS) and the development of progressive disease. Our aim was to investigate the TNF-alpha -376 polymorphism in primary progressive MS (PPMS) patients. Polymerase chain reaction and restriction fragment length polymorphism were carried out on 45 PPMS patients, 45 age and ...
Known for Multiple Sclerosis | Necrosis Factor | Alpha Gene | Primary Progressive
KOL-Index: 5127 . BACKGROUND: Neurofilament proteins (Nf) are highly specific biomarkers for neuronal death and axonal degeneration. As these markers become more widely used, an inter-laboratory validation study is required to identify assay criteria for high quality performance. METHODS: The UmanDiagnostics NF-light (R)enzyme-linked immunoabsorbent assays (ELISA) for the neurofilament light chain (NfL, ...
Known for Neurofilament Proteins | Protein Standards | Axonal Degeneration | Statistical Analyses
KOL-Index: 5049 . PRINCIPLES: Apolipoprotein E (ApoE), an important glycoprotein in the transport, uptake and redistribution of cholesterol, is necessary in nerve tissue repair. The APOE gene (APOE) is involved in neurodegenerative diseases, the best-known association being that between the APOE ε4 allele and Alzheimer's disease. Multiple sclerosis (MS) is a chronic inflammatory neurological disease. The ...
Known for Primary Progressive | Ε2 Allele | Apoe Gene | Multiple Sclerosis

Key People For Multiple Sclerosis

Top KOLs in the world
#1
Alanda K Thompson
multiple sclerosis spinal cord magnetic resonance
#2
Chris H Polman
multiple sclerosis magnetic resonance spinal cord
#3
Fred D Lublin
multiple sclerosis glatiramer acetate monoclonal antibodies
#4
Ludwig Kappos
multiple sclerosis disability progression magnetic resonance
#5
Massimo Filippi
multiple sclerosis magnetic resonance cervical cord
#6
Hans‐Peter Hartung
multiple sclerosis chronic inflammatory schwann cells

Department of Neurology, Faculty of Medicine, University of Szeged, Szeged, Hungary | Department of Neurology, Interdisciplinary Centre of Excellence, Faculty of Medicine, Albert Szent-Györgyi Clinical Centre, University of Szeged, Szeged, Hungary. |